Preventative health measures such as early ART (before AIDS) and targeted screening of asymptomatic cryptococcal antigenemia in individuals with a CD4 count<100 cells/μl are certainly more cost-effective to prevent disease than any of the aforementioned treatment options after cryptococcal disease has occurred [43]–[45]. The gene discussed is CD4; the disease is AIDS.